CDC73 and Hyperparathyroidism-jaw tumor syndrome: Inactivating mutations in CDC73 were first discovered in hyperparathyroidism-jaw tumor syndrome (HPT-JT), an autosomal dominant genetic disease featuring parathyroid tumors with fibro-osseous jaw tumors as well as uterine and renal lesions [4].